Trial Search Results

Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group

The Children's Oncology Group has established a research network, the Childhood Cancer Research Network (CCRN), to collect information about children with cancer and other conditions that are benign but involve abnormal cell growth in order to help doctors and scientists better understand childhood cancer. The CCRN's goal is to collect clinical information about every child diagnosed with cancer and similar conditions in the United States and Canada, to allow researchers to study patterns, characteristics, and causes of childhood cancer. The information can also help researchers study the causes of childhood cancer.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

National Cancer Institute (NCI)

Stanford Investigator(s):



   - Pre-CCRN Entry

   - All new patients seen in COG member institutions with any of the following diagnoses
   are eligible:

      - All cancer cases with an ICD-O histologic behavior code of two 2 (carcinoma in
      situ)or three 3 (malignant).

      - All lesions of the central nervous system regardless of behavior, i.e., benign,
      borderline or malignant.

      - The benign/borderline conditions which will be reportable by agreement shall
      include: Mesoblastic nephroma, all teratomas, regardless of locations, Theca cell

      - granulosa cell tumor, lymphoproliferative disease, ganglioneuroma,

myeloproliferative disease, Langerhan s Cell histiocytosis

Ages Eligible for Study

N/A - 18 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Not Recruiting